<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.3?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Mol Endocrinol</journal-id>
      <journal-id journal-id-type="publisher-id">JME</journal-id>
      <journal-title-group>
        <journal-title>Journal of Molecular Endocrinology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0952-5041</issn>
      <issn pub-type="epub">1479-6813</issn>
      <publisher>
        <publisher-name>Society for Endocrinology</publisher-name>
        <publisher-loc>Bristol</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3111094</article-id>
      <article-id pub-id-type="pmid">21367968</article-id>
      <article-id pub-id-type="publisher-id">JME110011</article-id>
      <article-id pub-id-type="doi">10.1530/JME-11-0011</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Regular Papers</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Localisation of the melanocortin-2-receptor and its accessory proteins in the developing and adult adrenal gland</article-title>
        <alt-title alt-title-type="short">Adrenal localisation of Mc2r and Mraps</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gorrigan</surname>
            <given-names>Rebecca J</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guasti</surname>
            <given-names>Leonardo</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>King</surname>
            <given-names>Peter</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Clark</surname>
            <given-names>Adrian J</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>Li F</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>William Harvey Research Institute</institution>
        <institution>Centre for Endocrinology Queen Mary, University of London Barts and The London School of Medicine and Dentistry</institution>
        <addr-line>London, EC1M 6BQ</addr-line>
        <country>UK</country>
      </aff>
      <author-notes>
        <corresp id="cor1">(Correspondence should be addressed to L F Chan; Email: <email>l.chan@qmul.ac.uk</email>)</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epreprint">
        <day>2</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <volume>46</volume>
      <issue>3</issue>
      <fpage>227</fpage>
      <lpage>232</lpage>
      <history>
        <date date-type="rev-recd">
          <day>21</day>
          <month>2</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>3</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2011 Society for Endocrinology</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://www.endocrinology.org/journals/reuselicence/">
          <license-p>This is an Open Access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://www.endocrinology.org/journals/reuselicence/">Society for Endocrinology's Re-use Licence</ext-link> which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The melanocortin-2-receptor (MC2R)/MC2R accessory protein (MRAP) complex is critical to the production of glucocorticoids from the adrenal cortex. Inactivating mutations in either <italic>MC2R</italic> or <italic>MRAP</italic> result in the clinical condition familial glucocorticoid deficiency. The localisation of MC2R together with MRAP within the adrenal gland has not previously been reported. Furthermore, MRAP2, a paralogue of MRAP, has been shown <italic>in vitro</italic> to have a similar function to MRAP, facilitating MC2R trafficking and responsiveness to ACTH. Despite similar MC2R accessory functions, <italic>in vivo</italic>, patients with inactivating mutations of <italic>MRAP</italic> fail to be rescued by a functioning <italic>MRAP2</italic> gene, suggesting differences in adrenal expression, localisation and/or function between the two MRAPs. In this study on the rat adrenal gland, we demonstrate that while MRAP and MC2R are highly expressed in the zona fasciculata, MRAP2 is expressed throughout the adrenal cortex in low quantities. In the developing adrenal gland, both MRAP and MRAP2 are equally well expressed. The MC2R/MRAP2 complex requires much higher concentrations of ACTH to activate compared with the MC2R/MRAP complex. Interestingly, expression of MC2R and MRAP in the undifferentiated zone would support the notion that ACTH may play an important role in adrenal cell differentiation and maintenance.</p>
      </abstract>
      <funding-group>
        <award-group>
          <funding-source id="CS200">Wellcome Clinical Research Training Fellowship</funding-source>
          <award-id rid="CS200">WT092024MA</award-id>
        </award-group>
        <award-group>
          <funding-source id="CS1">MRC/Academy of Medical Sciences Clinician Scientist Fellowship</funding-source>
          <award-id rid="CS1">G0802796</award-id>
        </award-group>
        <award-group>
          <funding-source id="CS2">MRC</funding-source>
          <award-id rid="CS2">G0700767</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="">
      <title>Introduction</title>
      <p>Glucocorticoids are produced by the zona fasciculata (ZF) of the adrenal cortex in response to ACTH stimulation of the melanocortin-2-receptor (MC2R), also known as the ACTH receptor. Ligand binding and activation of this G protein-coupled receptor principally results in stimulation of adenylyl cyclase, which catalyses the conversion of ATP to cAMP. Subsequent activation of protein kinase A leads to phosphorylation of cAMP response element protein, which in turn activates the transcription of genes involved in steroidogenesis (<xref ref-type="bibr" rid="bib10">Lefkowitz <italic>et al</italic>. 1970</xref>, <xref ref-type="bibr" rid="bib11">Lehoux <italic>et al</italic>. 1998</xref>).</p>
      <p>It has emerged over recent years that the MC2R is dependent on the co-expression of an accessory protein, the MC2R accessory protein (MRAP; <xref ref-type="bibr" rid="bib12">Metherell <italic>et al</italic>. 2005</xref>). The MC2R only responds to ACTH in heterologous cells when co-expressed with MRAP (<xref ref-type="bibr" rid="bib12">Metherell <italic>et al</italic>. 2005</xref>, <xref ref-type="bibr" rid="bib15">Roy <italic>et al</italic>. 2007</xref>, <xref ref-type="bibr" rid="bib16">Sebag &amp; Hinkle 2007</xref>), and knockdown of MRAP in mouse adrenal Y1 cells (<xref ref-type="bibr" rid="bib6">Cooray <italic>et al</italic>. 2008</xref>) and inactivating mutations in patients with familial glucocorticoid deficiency type 2 (FGD type 2; OMIM #607398) (<xref ref-type="bibr" rid="bib12">Metherell <italic>et al</italic>. 2005</xref>) lead to loss of ACTH responsiveness. It is also clear that <italic>MRAP</italic> mRNA is expressed in the adrenal gland (<xref ref-type="bibr" rid="bib12">Metherell <italic>et al</italic>. 2005</xref>). It is generally assumed that the glucocorticoid-producing fasciculata cell expresses both MC2R and MRAP, although this has not been formally established. Furthermore, MRAP has a single paralogue in the mammalian genome &#x2013; MRAP2. MRAP and MRAP2 share a 39% amino acid identity in the N-terminus and transmembrane domain (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>). The <italic>MRAP2</italic> gene is expressed in the brain and the adrenal gland. <italic>In vitro</italic> MRAP2 appears to have a qualitatively similar ability to MRAP, enabling MC2R trafficking from the endoplasmic reticulum to the cell surface and the formation of a functional ACTH receptor (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>). However, studies with mouse or zebrafish MRAP2 did not show this effect when a lower concentration of ACTH was used (<xref ref-type="bibr" rid="bib17">Sebag &amp; Hinkle 2009</xref>, <xref ref-type="bibr" rid="bib1">Agulleiro <italic>et al</italic>. 2010</xref>). Since the presence of MRAP2 in the adrenal gland does not protect patients with <italic>MRAP</italic> mutations from developing glucocorticoid deficiency, the question arises as to whether MRAP and MRAP2 are expressed at different levels, in different cell types or whether they differ functionally to lower doses of ACTH. In this study, we analysed the quantitative expression, anatomical localisation and functional properties of these two MRAPs.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec>
        <title>Plasmid and probes</title>
        <p>Vectors used in the cAMP reporter assays, MRAP-flag and MRAP2-flag were cloned, as previously described (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>). HA-MC2R was purchased from the Missouri S&amp;T cDNA Resource Center (University of Missouri at Rolla, Rolla, MO, USA). Templates for creating riboprobes for <italic>in situ</italic> hybridisation (ISH) were produced by inserting full-length <italic>Mrap</italic> (forward primer 5&#x2032;-CTGTCCCGTTCACCAGCTAT-3&#x2032;, reverse primer 5&#x2032;-TAACCATTGGTCAATGCCAG-3&#x2032;), <italic>Mrap2</italic> (forward primer 5&#x2032;-CTGTGAAGGGCTCTCTGACC-3&#x2032;, reverse primer 5&#x2032;-GAACACATCCTCAGGAAGGC-3&#x2032;), or <italic>Mc2r</italic> (forward primer 5&#x2032;-ATCTGCAGTTTGGCCATTTC-3&#x2032;, reverse primer 5&#x2032;-ATGCCATTGACCTGGAAGAG-3&#x2032;) cDNA produced from rat adrenal RNA into pGEMT-Easy vector (Promega). All constructs were confirmed by sequencing.</p>
      </sec>
      <sec>
        <title>Nonradioactive-ISH and immunohistochemistry</title>
        <p>Adrenal glands from adult Wistar male rats were snap frozen, or fixed in 4% paraformaldehyde and embedded in paraffin. Wistar rat embryos (embryonic day 17&#xB7;5) were collected in ice-cold PBS (Sigma), fixed in 4% paraformaldehyde, cryoprotected in 30% sucrose and embedded in OTC compound (Fisher Scientific, Loughborough, UK). Digoxigenin (DIG)-labelled sense and antisense cRNA riboprobe production and nonradioactive-ISH (NR-ISH), or combined NR-ISH/immunohistochemistry (IHC), were performed as reported by <xref ref-type="bibr" rid="bib7">Guasti <italic>et al</italic>. (2010)</xref>. Briefly, after NR-ISH staining, sections were blocked with 10% normal goat serum and incubated overnight at room temperature with anti-CYP11B1 mouse monoclonal antibody (a gift of Dr C Gomez-Sanchez, University of Mississippi Medical Center, Jackson, MS, USA) diluted 1:20 in PBS-Triton X-100 0&#xB7;1%. The sections were then washed and incubated for 2&#x200A;h with goat anti-rabbit Alexa Fluor 488 secondary (Invitrogen) diluted 1:1000 in PBS and, after further washes, reacted with 4&#x2032;,6-diamidino-2-phenylindole (DAPI; Sigma) for 1&#x200A;min. Images were captured using a Leica DC200 camera (Leica, Solms, Germany) equipped with a DCViewer software (Leica), imported into Photoshop (Adobe Systems), and bright field ISH images were converted into black and white, inverted and pseudo-coloured to red before merging them with the immunofluorescence images in RGB mode.</p>
      </sec>
      <sec>
        <title>Real-time quantitative RT-PCR</title>
        <p>cDNA was synthesised from rat total adrenal RNA (extracted from the adrenal glands of two adult male Wistar rats) by reverse transcription using M-MLV Reverse Transcriptase (Promega), following the manufacturer's guidelines. Gene expression levels were analysed by SYBR Green assays, using KAPA SYBR Fast Universal qPCR kit (Anachem, Luton, UK) and a Stratagene thermocycler. Thermal profile used: 1&#xD7; 95&#x200A;&#xB0;C for 3&#x200A;min, 40&#xD7; (95&#x200A;&#xB0;C for 3&#x200A;s, 55&#x200A;&#xB0;C for 20&#x200A;s and 72&#x200A;&#xB0;C for 1&#x200A;s), 1&#xD7; (95&#x200A;&#xB0;C for 1&#x200A;min, 55&#x200A;&#xB0;C for 30&#x200A;s and 95&#x200A;&#xB0;C for 30&#x200A;s). Primers used for rat cDNA were <italic>Mrap</italic> (forward, 5&#x2032;-ATTCTGCTCTACATGTCCTG-3&#x2032;, reverse, 5&#x2032;-TACTTCCTGGCTCATCTG-3&#x2032;) and <italic>Mrap2</italic> (forward, 5&#x2032;-CAGAGGCTGACTTCTAACAG-3&#x2032;, reverse, 5&#x2032;-CAGAATCCAATCACGATG-3&#x2032;). Gene expression of the housekeeping gene <italic>Gapdh</italic> was used for normalisation (forward, 5&#x2032;-TGCACCACCAACTGCTTAG-3&#x2032;, reverse, 5&#x2032;-GGATGCAGGGATGATGTTC-3&#x2032;) for rat cDNA. Experiments were performed in duplicate and repeated three times. Data were analysed using MxPro software (Stratagene, Stockport, UK). The <italic>C</italic><sub>t</sub> value of the unknown was quantified absolutely by interpolating the quantity from a standard curve, whose quantities were pre-determined spectrophotometrically at OD 260&#x200A;nm (NanoDrop ND-1000 spectrophotometer; Wilmington, DE, USA).</p>
      </sec>
      <sec>
        <title>Cell culture, transfection and cAMP reporter assay</title>
        <p>Human embryonic kidney (HEK293) cells were grown in DMEM (Sigma) containing 10% foetal bovine serum (Sigma) and penicillin/streptomycin (Invitrogen). Cells were grown to around 70&#x2013;80% confluency in six-well plates and transfected with HA-MC2R, plus either MRAP-flag, MRAP2-flag, MRAP-flag and MRAP2-flag or pcDNA 3.1(+) empty vector, along with &#x3B1;GSU-846 luciferase and pRL-CMV <italic>Renilla</italic> luciferase plasmid constructs, using Lipofectamine 2000 (Invitrogen), following the manufacturer's instructions. Twenty-four to forty-eight hours after transfection, cells were stimulated for 6&#x200A;h with ACTH<sub>1&#x2013;39</sub> at concentrations of 10<sup>&#x2212;4</sup> to 10<sup>&#x2212;11</sup>&#x200A;M. Whole cell lysates were collected and assayed using the Dual-Luciferase Reporter Assay System (Promega). Luciferase activity was measured using a multiplate reader (LUMIstar Omega; BMG Labtech, Aylesbury, UK) and normalised to the pRL-CMV <italic>Renilla</italic> luciferase activity.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>The data represent mean&#xB1;<sc>s.e.m.</sc> of at least three independent experiments performed in duplicate. Prism software (La Jolla, CA, USA) was used to evaluate EC<sub>50</sub> values. Statistical analysis was performed using Student's <italic>t</italic>-test.</p>
      </sec>
    </sec>
    <sec sec-type="">
      <title>Results</title>
      <sec>
        <title><italic>Mrap</italic>, <italic>Mrap2</italic> and <italic>Mc2r</italic> localisation in the adult and foetal rat adrenal gland</title>
        <p>ISH was performed to visualise the localisation of <italic>Mrap</italic>, <italic>Mrap2</italic> and <italic>Mc2r</italic> mRNA expression within the adrenal gland (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). <italic>Mrap</italic> and <italic>Mrap2</italic> were readily detectable specifically in the adrenal gland during development (<xref ref-type="fig" rid="fig1">Fig. 1A</xref>&#x2013;F). <italic>Mrap</italic> and <italic>Mrap2</italic> NR-ISH was performed in combination with CYP11B1 IHC, which demonstrated that cortical, but not medullary cells, expressed <italic>Mc2r</italic> accessory proteins (<xref ref-type="fig" rid="fig1">Fig. 1G</xref>&#x2013;G&#x2033;).</p>
        <p>In the adult adrenal gland, <italic>Mrap</italic> and <italic>Mc2r</italic> were expressed throughout the cortex (<xref ref-type="fig" rid="fig1">Fig. 1H</xref>&#x2013;K), although their expression was weaker in the zona glomerulosa (ZG) compared with the ZF. In the ZF, a gradient was observed with higher levels of expression seen at the periphery decreasing towards the cortico-medullary boundary. When combined <italic>Mc2r</italic> NR-ISH/CYP11B1 IHC was performed, the inner layer of cells within the undifferentiated zone (ZU), also known as the zona intermedia, which was negative for CYP11B1, was strongly positive for <italic>Mc2r</italic> expression (<xref ref-type="fig" rid="fig1">Fig. 1L</xref>&#x2013;L&#x2033;). Combined <italic>Mrap</italic> NR-ISH/CYP11B1 IHC revealed the same pattern of expression (data not shown). In contrast, <italic>Mrap2</italic> was detected at low levels throughout all zones of the adrenal cortex (<xref ref-type="fig" rid="fig1">Fig. 1M</xref>).</p>
      </sec>
      <sec>
        <title>Quantification of <italic>Mrap</italic> and <italic>Mrap2</italic> in rat adrenal gland</title>
        <p>Quantitative PCR was performed on rat total adrenal gland cDNA for <italic>Mrap</italic> and <italic>Mrap2</italic> expression. Results were expressed relative to <italic>Gapdh</italic> or copy numbers per reaction. <italic>Mrap</italic> was expressed at significantly higher levels compared with <italic>Mrap2</italic> (18&#xD7; greater than <italic>Mrap2</italic> when expressed relative to <italic>Gapdh</italic>, <italic>P</italic>&lt;0&#xB7;0001, and 21&#xD7; greater when expressed as copy number per reaction, <italic>P</italic>=0&#xB7;0015; <xref ref-type="fig" rid="fig2">Fig. 2</xref>).</p>
      </sec>
      <sec>
        <title>Functional MC2R differences between MRAP and MRAP2</title>
        <p>HEK293 cells, which lack endogenous melanocortin receptors, were transfected with MC2R and either MRAP, MRAP2 or both. Stimulation with ACTH generated a dose-dependent increase in cAMP production, as assessed by the luciferase activity produced from the cAMP-responsive &#x3B1;GSU-846 luciferase reporter construct. Cells transfected with MC2R and MRAP2 were able to produce cAMP; however they required significantly higher concentrations of ACTH to achieve this (EC50 1&#xD7;10<sup>&#x2212;9</sup> for MRAP and 9&#xB7;3&#xD7;10<sup>&#x2212;7</sup> for MRAP2; <italic>P</italic>&lt;0&#xB7;0001). Cells expressing both MRAP and MRAP2 did not exhibit a reduction or augmentation of the MRAP/MC2R cAMP response to ACTH stimulation (<xref ref-type="fig" rid="fig3">Fig. 3</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="">
      <title>Discussion</title>
      <p>The importance of MRAP in MC2R function is exemplified by the clinical condition of FGD, in which disabling mutations of either gene results in life-threatening isolated glucocorticoid deficiency (<xref ref-type="bibr" rid="bib12">Metherell <italic>et al</italic>. 2005</xref>). Although the expression of <italic>MRAP</italic> has been demonstrated in the adrenal gland by RT-PCR, little is known about the localisation of <italic>MRAP</italic> mRNA within the different zones of the adrenal gland (<xref ref-type="bibr" rid="bib12">Metherell <italic>et al</italic>. 2005</xref>). In addition, the presence of MRAP2 in the adrenal gland could indicate the potential for redundancy (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>), although this is unlikely as patients with <italic>MRAP</italic> mutations are not rescued by an intact <italic>MRAP2</italic> gene.</p>
      <p>Our ISH studies have shown that <italic>Mrap</italic> and <italic>Mc2r</italic> are highly expressed in the rat adrenal ZF in cells expressing CYP11B1 and thus being capable of glucocorticoid synthesis. The level of expression appears to be highest at the periphery, with a gradient reduction towards the medulla. Interestingly, the highest level of <italic>Mrap</italic> and <italic>Mc2r</italic> expression is in the inner part of ZU, directly adjacent to the ZF. The ZU lies between the ZF and ZG in the adult rat adrenal and has been postulated to contain stem cells that contribute to steroidogenic cell maintenance (<xref ref-type="bibr" rid="bib19">Wright &amp; Voncina 1977</xref>, <xref ref-type="bibr" rid="bib13">Mitani <italic>et al</italic>. 2003</xref>). Expression of <italic>Mrap</italic> and <italic>Mc2r</italic> in the ZU in relatively undifferentiated, CYP11B1-negative cells is interesting and suggests that ACTH may have a role in adrenal cell differentiation and maintenance. The concept that ACTH plays an important role on adrenal growth and adrenal zonal maintenance has been proposed for some time (reviewed in <xref ref-type="bibr" rid="bib9">Karpac <italic>et al</italic>. (2007)</xref> and <xref ref-type="bibr" rid="bib3">Chan <italic>et al</italic>. (2011)</xref>). Hypophysectomised animal models have adrenocortical atrophy (<xref ref-type="bibr" rid="bib14">Robinson <italic>et al</italic>. 1983</xref>) and similarly atrophied adrenal glands were noted in POMC-knockout mice (<xref ref-type="bibr" rid="bib5">Coll <italic>et al</italic>. 2004</xref>, <xref ref-type="bibr" rid="bib8">Karpac <italic>et al</italic>. 2005</xref>). The administration of ACTH alone appeared to restore adrenal weight, morphology and function to normal in these models (<xref ref-type="bibr" rid="bib14">Robinson <italic>et al</italic>. 1983</xref>, <xref ref-type="bibr" rid="bib5">Coll <italic>et al</italic>. 2004</xref>). The adrenal histology of FGD would support the suggestion that MC2R and/or MRAP may be important for adrenal zonal development as the glands from deceased patients demonstrate disorganisation of glomerulosa cells with almost complete absence of fasciculata and reticularis cells (<xref ref-type="bibr" rid="bib4">Clark &amp; Weber 1998</xref>).</p>
      <p>In comparison to the high expression levels seen with <italic>Mrap</italic> and <italic>Mc2r</italic>, ISH studies for <italic>Mrap2</italic> showed very low levels of expression in adult rat adrenal but high expression in the developing adrenal gland. Real-time RT-PCR quantification of <italic>Mrap</italic> and <italic>Mrap2</italic> expression in the adult rat adrenal gland demonstrated that <italic>Mrap</italic> expression is significantly greater than <italic>Mrap2</italic> expression, supporting the low expression levels detected by ISH.</p>
      <p>We previously showed that MRAP2 was able to rescue the expression and function of the MC2R in non-adrenal cells (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>). Later studies, however, suggested that although MRAP2 was capable of assisting MC2R to the cell surface, the receptor was unresponsive to ACTH (<xref ref-type="bibr" rid="bib17">Sebag &amp; Hinkle 2009</xref>, <xref ref-type="bibr" rid="bib1">Agulleiro <italic>et al</italic>. 2010</xref>). Here, we demonstrate that MRAP2 does indeed enable functioning of the MC2R in response to ACTH stimulation <italic>in vitro</italic>; however, much higher concentrations of ACTH are required to generate the same amount of cAMP in the presence of MRAP2 compared with MRAP. The 1000-fold difference in EC<sub>50</sub> provides an explanation and hence agreement for the different results obtained by other groups who utilised different ACTH doses for stimulation (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>, <xref ref-type="bibr" rid="bib17">Sebag &amp; Hinkle 2009</xref>, <xref ref-type="bibr" rid="bib1">Agulleiro <italic>et al</italic>. 2010</xref>). It is likely that even in FGD type 2, where ACTH concentrations are often &gt;1000&#x200A;pg/ml (<xref ref-type="bibr" rid="bib4">Clark &amp; Weber 1998</xref>), this is still inadequate to stimulate MC2R function. This suggests that although MRAP2 can enable MC2R function, this is not its role <italic>in vivo</italic>.</p>
      <p>Studies have shown that MRAP2 can heterodimerise with MRAP <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>) and such heterodimers adopt an antiparallel conformation (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>, <xref ref-type="bibr" rid="bib18">Sebag &amp; Hinkle 2010</xref>). Western blotting of tissues has revealed band sizes of which are suggestive of homodimers rather than heterodimers (<xref ref-type="bibr" rid="bib6">Cooray <italic>et al</italic>. 2008</xref>, <xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>). Nevertheless, experiments on Y1 and CHO cells suggest that MRAP2 has an inhibitory role and competes with MRAP to bind the MC2R, reducing cAMP production in response to ACTH stimulation (<xref ref-type="bibr" rid="bib18">Sebag &amp; Hinkle 2010</xref>) <italic>in vitro</italic>. In this study, we did not show any reduction in cAMP generation of the MRAP/MC2R complex with the addition of MRAP2. Likewise, another study on zebrafish MRAP2 did not report an inhibitory effect, but found that MRAP2 had additive effects on the MRAP/MC2R cAMP response to ACTH (<xref ref-type="bibr" rid="bib1">Agulleiro <italic>et al</italic>. 2010</xref>). This may, however, represent the different cell lines used in the studies and hence different levels of expression achieved (<xref ref-type="bibr" rid="bib2">Chan <italic>et al</italic>. 2009</xref>, <xref ref-type="bibr" rid="bib1">Agulleiro <italic>et al</italic>. 2010</xref>, <xref ref-type="bibr" rid="bib18">Sebag &amp; Hinkle 2010</xref>). While the hypothesis of a dominant-negative action of MRAP2 is an attractive one, it is difficult to envisage such a mechanism in view of the low levels of MRAP2 expression in adrenal tissue, the diffuse zonal localisation in the adrenal gland and the amount of MRAP2 expression that may be required to significantly shift the EC<sub>50</sub> for this to be relevant. Whether MRAP2 expression in the foetal adrenal gland determines the tone of the hypothalamic&#x2013;pituitary&#x2013;adrenal axis in adult life has yet to be studied and can only be answered with the generation of knockout mice.</p>
      <p>In conclusion, we have demonstrated that <italic>Mc2r</italic>, <italic>Mrap</italic> and CYP11B1 are co-expressed in fasciculata cells in the rat adrenal gland, consistent with their role in ACTH stimulation of steroidogenesis. Furthermore, <italic>Mrap</italic> and <italic>Mc2r</italic> are expressed in some cells of the rat adrenal ZU, suggesting that ACTH may be important in adrenal cell differentiation and maintenance. The role of MRAP2 in the adrenal gland is unclear. Although MRAP2 is capable of facilitating MC2R function in response to ACTH stimulation, the concentration of ACTH required is much higher than that likely to be generated <italic>in vivo</italic>. However, the apparent high expression of MRAP2 in the developing adrenal gland may suggest a role in early development. Availability of global or tissue-specific <italic>Mrap2</italic>-knockout mice would certainly help clarify the role of this protein during development and in adult homeostasis.</p>
    </sec>
    <sec sec-type="">
      <title>Declaration of interest</title>
      <p>The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.</p>
    </sec>
    <sec sec-type="">
      <title>Funding</title>
      <p>R J G is supported by a Wellcome Clinical Research Training Fellowship (grant number WT092024MA). L F C holds an MRC/Academy of Medical Sciences Clinician Scientist Fellowship (grant number G0802796). L G is supported by an MRC project grant awarded to PJK (grant number G0700767).</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors thank Dr C Gomez-Sanchez (University of Mississippi Medical Center, Jackson, Mississippi) for providing the CYP11B1 antibodies.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agulleiro</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Puchol</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gallo-Payet</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cerda-Reverter</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Role of melanocortin receptor accessory proteins in the function of zebrafish melanocortin receptor type 2</article-title>
          <source>Molecular and Cellular Endocrinology</source>
          <volume>320</volume>
          <year>2010</year>
          <fpage>145</fpage>
          <lpage>152</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1016/j.mce.2010.01.032">doi:10.1016/j.mce.2010.01.032</ext-link>
          <pub-id pub-id-type="pmid">20138960</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Meimaridou</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cooray</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Guasti</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chapple</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Egertova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Elphick</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Cheetham</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family</article-title>
          <source>PNAS</source>
          <volume>106</volume>
          <year>2009</year>
          <fpage>6146</fpage>
          <lpage>6151</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1073/pnas.0809918106">doi:10.1073/pnas.0809918106</ext-link>
          <pub-id pub-id-type="pmid">19329486</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Metherell</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Effects of melanocortins on adrenal gland physiology</article-title>
          <source>European Journal of Pharmacology</source>
          <year>2011</year>
          <comment>(In Press)</comment>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1016/j.ejphar.2010.11.041">doi:10.1016/j.ejphar.2010.11.041</ext-link>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Adrenocorticotropin insensitivity syndromes</article-title>
          <source>Endocrine Reviews</source>
          <volume>19</volume>
          <year>1998</year>
          <fpage>828</fpage>
          <lpage>843</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1210/er.19.6.828">doi:10.1210/er.19.6.828</ext-link>
          <pub-id pub-id-type="pmid">9861547</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coll</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Challis</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Yeo</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Snell</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Piper</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Halsall</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Thresher</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>O'Rahilly</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin</article-title>
          <source>Endocrinology</source>
          <volume>145</volume>
          <year>2004</year>
          <fpage>4721</fpage>
          <lpage>4727</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1210/en.2004-0491">doi:10.1210/en.2004-0491</ext-link>
          <pub-id pub-id-type="pmid">15231703</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooray</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Almiro Do Vale</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Chapple</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Egertova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cheetham</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Elphick</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse Y1 cell line</article-title>
          <source>Endocrinology</source>
          <volume>149</volume>
          <year>2008</year>
          <fpage>1935</fpage>
          <lpage>1941</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1210/en.2007-1463">doi:10.1210/en.2007-1463</ext-link>
          <pub-id pub-id-type="pmid">18162519</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guasti</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Laufer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Localization of Sonic hedgehog secreting and receiving cells in the developing and adult rat adrenal cortex</article-title>
          <source>Molecular and Cellular Endocrinology</source>
          <volume>336</volume>
          <year>2010</year>
          <fpage>117</fpage>
          <lpage>122</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1016/j.mce.2010.11.010">doi:10.1016/j.mce.2010.11.010</ext-link>
          <pub-id pub-id-type="pmid">21094676</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karpac</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ostwald</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bui</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hunnewell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shankar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hochgeschwender</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Development, maintenance, and function of the adrenal gland in early postnatal proopiomelanocortin-null mutant mice</article-title>
          <source>Endocrinology</source>
          <volume>146</volume>
          <year>2005</year>
          <fpage>2555</fpage>
          <lpage>2562</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1210/en.2004-1290">doi:10.1210/en.2004-1290</ext-link>
          <pub-id pub-id-type="pmid">15731356</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karpac</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hochgeschwender</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Pro-opiomelanocortin peptides and the adrenal gland</article-title>
          <source>Molecular and Cellular Endocrinology</source>
          <volume>265&#x2013;266</volume>
          <year>2007</year>
          <fpage>29</fpage>
          <lpage>33</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1016/j.mce.2006.12.035">doi:10.1016/j.mce.2006.12.035</ext-link>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lefkowitz</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pricer</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Pastan</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase</article-title>
          <source>PNAS</source>
          <volume>65</volume>
          <year>1970</year>
          <fpage>745</fpage>
          <lpage>752</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1073/pnas.65.3.745">doi:10.1073/pnas.65.3.745</ext-link>
          <pub-id pub-id-type="pmid">4315615</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lehoux</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Fleury</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ducharme</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>The acute and chronic effects of adrenocorticotropin on the levels of messenger ribonucleic acid and protein of steroidogenic enzymes in rat adrenal <italic>in vivo</italic></article-title>
          <source>Endocrinology</source>
          <volume>139</volume>
          <year>1998</year>
          <fpage>3913</fpage>
          <lpage>3922</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1210/en.139.9.3913">doi:10.1210/en.139.9.3913</ext-link>
          <pub-id pub-id-type="pmid">9724047</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Metherell</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Chapple</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Cooray</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>David</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ruschendorf</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Naville</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Begeot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Khoo</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nurnberg</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2</article-title>
          <source>Nature Genetics</source>
          <volume>37</volume>
          <year>2005</year>
          <fpage>166</fpage>
          <lpage>170</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1038/ng1501">doi:10.1038/ng1501</ext-link>
          <pub-id pub-id-type="pmid">15654338</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitani</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mukai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Suematsu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ishimura</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>The undifferentiated cell zone is a stem cell zone in adult rat adrenal cortex</article-title>
          <source>Biochimica et Biophysica Acta</source>
          <volume>1619</volume>
          <year>2003</year>
          <fpage>317</fpage>
          <lpage>324</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1016/S0304-4165(02)00490-7">doi:10.1016/S0304-4165(02)00490-7</ext-link>
          <pub-id pub-id-type="pmid">12573491</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Comline</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Fowden</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Adrenal cortex of fetal lamb: changes after hypophysectomy and effects of Synacthen on cytoarchitecture and secretory activity</article-title>
          <source>Quarterly Journal of Experimental Physiology</source>
          <volume>68</volume>
          <year>1983</year>
          <fpage>15</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">6298852</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rached</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gallo-Payet</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells</article-title>
          <source>Molecular Endocrinology</source>
          <volume>21</volume>
          <year>2007</year>
          <fpage>1656</fpage>
          <lpage>1669</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1210/me.2007-0041">doi:10.1210/me.2007-0041</ext-link>
          <pub-id pub-id-type="pmid">17456795</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebag</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Hinkle</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers</article-title>
          <source>PNAS</source>
          <volume>104</volume>
          <year>2007</year>
          <fpage>20244</fpage>
          <lpage>20249</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1073/pnas.0708916105">doi:10.1073/pnas.0708916105</ext-link>
          <pub-id pub-id-type="pmid">18077336</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebag</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Hinkle</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling</article-title>
          <source>Journal of Biological Chemistry</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>610</fpage>
          <lpage>618</lpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1074/jbc.M804413200">doi:10.1074/jbc.M804413200</ext-link>
          <pub-id pub-id-type="pmid">18981183</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebag</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Hinkle</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2</article-title>
          <source>Science Signaling</source>
          <volume>3</volume>
          <year>2010</year>
          <fpage>ra28</fpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/doi:10.1126/scisignal.2000593">doi:10.1126/scisignal.2000593</ext-link>
          <pub-id pub-id-type="pmid">20371771</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wright</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Voncina</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Studies on the postnatal growth of the rat adrenal cortex</article-title>
          <source>Journal of Anatomy</source>
          <volume>123</volume>
          <year>1977</year>
          <fpage>147</fpage>
          <lpage>156</lpage>
          <pub-id pub-id-type="pmid">838620</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="fig1" position="float">
      <label>Figure 1</label>
      <caption>
        <p><italic>In situ</italic> hybridisation showing localisation of <italic>Mrap</italic>, <italic>Mrap2</italic> and <italic>Mc2r</italic> in foetal and adult Wistar rat adrenal glands. (A&#x2013;G) Foetal Wistar rat adrenal glands (embryonic age 17&#xB7;5 days); (H&#x2013;N) adult male Wistar rat adrenal glands. (A and B) Low-magnification images of foetal rat adrenal glands incubated with <italic>Mrap</italic> antisense and sense (S) riboprobes. <italic>Mrap</italic> is present throughout the foetal rat adrenal gland. The sense probe resulted in no specific staining. (C and D) 10&#xD7; magnified images of foetal rat adrenal glands. No <italic>Mrap</italic> staining in the adrenal capsule (C) or subcapsular zone (indicated by T). (E and F) Foetal rat adrenal glands incubated with <italic>Mrap2</italic> antisense and sense (S) riboprobes. <italic>Mrap2</italic> is present throughout the foetal rat adrenal gland. The sense probe resulted in no specific staining. (G) Combined <italic>Mrap</italic> ISH and CYP11B1 immunohistochemistry. Nuclei are stained with DAPI. Cells positive for <italic>Mrap</italic> also express CYP11B1, suggesting these cells are capable of glucocorticoid synthesis and are destined to localise to the zona fasciculata postnatally. (H&#x2013;K) <italic>Mc2r</italic> and <italic>Mrap</italic> are present in the zona fasciculata (ZF), with relative sparing of the capsule, zona glomerulosa (ZG) and medulla (M). Expression was strongest at the periphery, with a gradient reduction towards the medulla. The sense probes resulted in no specific staining (h, j). (L) Combined <italic>Mc2r</italic> ISH and CYP11B1 immunohistochemistry. <italic>Mc2r</italic> is expressed in the ZF, in cells co-expressing CYP11B1. <italic>Mc2r</italic> is also expressed highly in the undifferentiated zone, in cells which lack CYP11B1 expression. (M and N) <italic>Mrap2</italic> is expressed at low levels throughout the adult rat adrenal gland. The sense probe resulted in no specific staining (N).</p>
      </caption>
      <graphic xlink:href="JME110011f01"/>
    </fig>
    <fig id="fig2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Quantification of <italic>Mrap</italic> and <italic>Mrap2</italic> in rat adrenal gland. Expression of <italic>Mrap</italic> and <italic>Mrap2</italic> in total adult Wistar rat adrenal glands (A) normalised to <italic>Gapdh</italic> showing a 18-fold reduction in <italic>Mrap2</italic> relative to <italic>Mrap</italic> (<italic>P</italic>&lt;0&#xB7;0001), <italic>n</italic>=3. (B) Expressed as copy numbers per reaction showing a 21-fold reduction in <italic>Mrap2</italic> relative to <italic>Mrap</italic> (<italic>P</italic>=0&#xB7;0015), <italic>n</italic>=3. (C) Agarose gel image demonstrating the expression of <italic>Mrap</italic> and <italic>Mrap2</italic> in rat adrenal gland by RT-PCR.</p>
      </caption>
      <graphic xlink:href="JME110011f02"/>
    </fig>
    <fig id="fig3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>MC2R response to ACTH in the presence of MRAP or MRAP2 or both. HEK293 cells were transiently transfected with HA-MC2R, &#x3B1;GSU846-luc, pRL-CMV <italic>Renilla</italic> luciferase and either MRAP-Flag, MRAP2-Flag, MRAP-Flag and MRAP2-Flag or empty vector together with and stimulated with ACTH for 6&#x200A;h. Dose&#x2013;response curves demonstrating a right shift in the case of MRAP2. EC50 1&#xD7;10<sup>&#x2212;9</sup> for MRAP and 9&#xB7;3&#xD7;10<sup>&#x2212;7</sup> for MRAP2; <italic>P</italic>&lt;0&#xB7;0001. EV, empty vector.</p>
      </caption>
      <graphic xlink:href="JME110011f03"/>
    </fig>
  </floats-group>
</article>
